EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

3566 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE:

# Side effect Count
0 NAUSEA 249
1 BLOOD GLUCOSE INCREASED 238
2 VOMITING 212
3 DIABETIC KETOACIDOSIS 190
4 DIARRHOEA 185
5 WEIGHT DECREASED 184
6 FATIGUE 148
7 DIZZINESS 146
8 DRUG INEFFECTIVE 146
9 KETOACIDOSIS 129
See all common reactions for EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL DISORDER 25 0.0549
1 ALLERGIC SINUSITIS 26 0.0303
2 EUGLYCAEMIC DIABETIC KETOACIDOSIS 87 0.0211
3 KETOACIDOSIS 129 0.0172
4 KETONURIA 14 0.0172
5 VITAMIN B12 DECREASED 25 0.0087
6 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 10 0.0083
7 PANCREATIC NEOPLASM 10 0.0081
8 DIABETIC KETOACIDOSIS 190 0.0079
9 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
See all enriched reactions for EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE